期刊文献+

肌萎缩侧索硬化患者血清氧化标记物表达水平与病情严重程度的相关性分析 被引量:3

Correlation between expression level of serum oxidation markers and disease severity in patients with amyotrophic lateral sclerosis
下载PDF
导出
摘要 目的探讨氧化应激在肌萎缩侧索硬化(ALS)发病中的作用及其与病情评价指标的相关性。方法应用酶联免疫吸附测定(ELISA)法、硫代巴比妥酸法以及黄嘌呤氧化酶法分别测定39例ALS患者和43例正常对照者血清中8-羟基脱氧鸟苷酸(8-OhdG)、丙二醛(MDA)、谷胱甘肽(GSH)的水平;采用量表评价病情严重程度。结果ALS组血清中8-OhdG(195.02±51.47)ng/L和MDA(8.34±1.67)nmol/L明显高于对照组(122.47±56.87)ng/L和(3.47±1.17)nmol/L(P<0.05);ALS组血清中GSH(18.34±2.55)nmol/L明显低于对照组血清中GSH(28.34±3.87)nmol/L(P<0.05)。ALS组血清中8-OhdG、MDA及GSH的水平与病情严重程度有相关性(P<0.05)。结论ALS患者出现了明显的氧化损伤;血清中8-OhdG、MDA及GSH的水平与ALS病情轻重相关。 Objective To explore the effects of oxidative stress in amyotrophic lateral sclerosis(ALS)and its relevance with the disease evaluation index.Methods The level of 8-hydroxy deoxyguansine acid(8-OhdG),malondialdehyde(MDA)and glutathione(GSH)in 39 cases of ALS and 43 normal controls were detected by enzymelinked immunosorbent assay(ELISA),thiobarbituric acid and xanthine oxidase technique.The severity of disease was evaluated by using rating scale.Results The 8-OhdG(195.02±51.47)ng/L and MDA(8.34±1.67)nmol/L in the serum of patients were significantly higher than those in the control group(122.47±56.87)ng/L and(3.47±1.17)nmol/L(P 0.05).The GSH level(18.34±2.55)nmol/L in the serum of patients was significantly lower than that in the control group(28.34±3.87)nmol/L(P 0.01).2There were relevance between the level of 8-OhdG,MDA and GSH and the disease severity in the patients(P 0.05).Conclusion Obvious oxidative damage exists in ALS patients.The levels of 8-OhdG,MAD and GSH are closely related to the severity of ALS patients.
出处 《临床荟萃》 CAS 2014年第8期856-858,共3页 Clinical Focus
关键词 肌萎缩侧索硬化 氧化应激 酶联免疫吸附测定 amyotrophic lateral sclerosis oxidative stress enzyme-linked immunosorbent assay
  • 相关文献

参考文献12

二级参考文献86

  • 1张骏,邓宏宇,巫刚,李双庆.多发性骨髓瘤148例临床分析[J].临床荟萃,2005,20(8):452-454. 被引量:24
  • 2Sussmuth SD, Tumani H, Ecker D, et al. Amyotrophic lateral sclerosis:disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum[J]. Neurosci Lett,2003,353(1) :57-60.
  • 3Strong MJ, Yang W, Strong WL, et al. Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment[J]. Neurology, 2006,66 (11 ) : 1770-1771.
  • 4Paladino P,Valentino F,Piccoli T,et al. Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis[J]. Eur J Neurol,2009,16(2) :257-261.
  • 5Conrad C, Vianna C, Freeman M, et al. A polymorphie gene nested within an intron of the tau gene: implications for Alzheimer' s disease[J]. Proc Natl Acad Sci USA, 2002, 99 (11) :7751-7756.
  • 6Glatz DC,Rujescu D, Tang Y,et al. The alternative splicing of tau exon 10 and it s regulatory proteins CLK2 and TRA2- BETA1 changes in sporadic Alzheimer's disease [J]. J Neurochem, 2006,96 (3) : 635-644.
  • 7Levecque C, Elbaz A, Clavel J, et al. Association of polymorphisms in the Tau and Saitohin genes with Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2004,75 (3) : 478- 480.
  • 8Jankovic N, Kecmanovic M, Dimitrijevic R, et al. HD phenocopies-possible role of Saitohin gene[J]. Int J Neurosci, 2008,118(3):391-397.
  • 9de Silva R, Hope A,Pittman A,et al. Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy [J]. Neurology, 2003,61 (3) : 407-409.
  • 10Zekanowski C, Peplonska B, Styczynska M, et al. Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia [J]. Dement Geriatr Cogn Disord,2003,16(3) : 126-131.

共引文献58

同被引文献21

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部